Durable Responses With Maintenance Dose-Sparing Regimens of Romidepsin in Cutaneous T-Cell Lymphoma-Reference-Cited by-同舟云学术

Durable Responses With Maintenance Dose-Sparing Regimens of Romidepsin in Cutaneous T-Cell Lymphoma

Published:2016-06-01 Issue:6 Volume:2 Page:790
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Martinez-Escala M. Estela¹,Kuzel Timothy M.²,Kaplan Jason B.³,Petrich Adam²,Nardone Beatrice¹,Rosen Steven T.⁴,Guitart Joan¹

Affiliation:

1. Department of Dermatology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois

2. Division of Hematology/Oncology, Department of Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois

3. Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, Illinois

4. Comprehensive Cancer Center and Beckman Research Institute, City of Hope, Duarte, California

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma;Journal of Investigative Dermatology;2024-07

2. GATA-3–dependent Gene Transcription is Impaired upon HDAC Inhibition;Clinical Cancer Research;2024-01-02

3. Mycosis fungoides and Sézary syndrome;Blood Research;2023-04-30

4. Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome;Blood;2023-02-16

5. Cutaneous T‐cell lymphomas: 2023 update on diagnosis, risk‐stratification, and management;American Journal of Hematology;2022-10-20